A new triple combination cystic fibrosis transmembrane regulator modulator

Lancet Respir Med. 2023 Jun;11(6):499-500. doi: 10.1016/S2213-2600(23)00001-2. Epub 2023 Feb 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aminophenols / therapeutic use
  • Aminopyridines / therapeutic use
  • Benzodioxoles / therapeutic use
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / drug therapy
  • Humans
  • Mutation

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Aminopyridines
  • Aminophenols
  • Benzodioxoles